Wyeth outlines HT risks and guidance for menopausal care
Wyeth summarizes recent HT study findings linking higher dementia risk in women 65 to 79, notes these data updated prescribing information, and emphasizes HT remains appropriate for some menopausal symptoms. They advise shared decision making, short duration at lowest effective dose, regular reevaluation, and consideration of alternatives plus lifestyle measures.